Related Experiment Video

Updated: Aug 14, 2026

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Côte d'Ivoire, 1997-2000

Roger Salamon1, Catherine Marimoutou, Daniel Ekra

  • 1Unité INSERM 330, ISPED, Université Victor Segalen Bordeaux 2, Bordeaux, France. roger.salamon@isped.u-bordeaux2.fr

Journal of Acquired Immune Deficiency Syndromes (1999)
|February 8, 2002
PubMed

Insights

This study tracked HIV-1 infection in Africa, finding that while viral loads remained high, most patients stayed asymptomatic with few clinical events over three years. This highlights the importance of monitoring for long-term health outcomes in HIV-1 patients.

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Understanding the natural history of Human Immunodeficiency Virus type 1 (HIV-1) infection is crucial for developing effective treatment and management strategies.
  • Previous studies on HIV-1 evolution in African populations are limited, necessitating further research into clinical and biological progression in this region.

Purpose of the Study:

  • To prospectively describe the clinical and biological evolution of HIV-1 infection in a cohort of individuals in Abidjan, Côte d'Ivoire.
  • To assess key markers such as CD4+ cell counts and plasma HIV RNA levels, alongside clinical events, in early HIV-1 infection.

Main Methods:

  • Prospective identification of 104 HIV-1-infected individuals from blood donors in Abidjan, Côte d'Ivoire.
  • Estimation of seroconversion dates and 6-month follow-up for biologic and clinical assessments.
  • Case management followed national guidelines, with 95% receiving co-trimoxazole prophylaxis.

Main Results:

  • Median follow-up was 23.9 months; median CD4+ cell count at baseline was 527/mm³, declining 20-25/mm³ annually.
  • Median plasma HIV RNA levels stabilized above 4 log 10 copies/ml, with few patients experiencing AIDS-defining events (3-year AIDS-free probability: 96.7%).
  • 17 patients had Centers for Disease Control and Prevention category B events; 1 presented with wasting syndrome, and 3 developed tuberculosis.

Conclusions:

  • HIV-1 seroconverters in this African cohort exhibited moderate immunosuppression with persistently high viral loads.
  • Despite high viral RNA levels, clinical progression was slow, with a low incidence of severe opportunistic infections or AIDS-defining illnesses within the first three years.
  • These findings underscore the importance of continued monitoring and prophylactic measures in managing HIV-1 infection in African populations.
Abstract

More Related Videos

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing10:18

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...